INTERNATIONAL PATENT: REVERAGEN BIOPHARMA, INC. FILES APPLICATION FOR "TREATMENT OF GLOMERULONEPHRITIS"

GENEVA, Oct. 1 -- REVERAGEN BIOPHARMA, INC. (155 Gibbs StreetSuite 433Rockville, Maryland 20850) filed a patent application (PCT/US2025/020739) for "TREATMENT OF GLOMERULONEPHRITIS" on Mar 20, 2025. With publication no. WO/2025/199347, the details related to the patent application was published on Sep 25, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): HOFFMAN, Eric (c/o ReveraGen BioPharma, Inc.155 Gibbs StreetSuite 433Rockville, Maryland 20850), HAGERTY, Laura (c/o ReveraGen BioPharma, Inc.155 Gibbs StreetSuite 433Rockville, Maryland 20850), DAMSKER, Jesse (c/o ReveraGen BioPharma, Inc.155...